Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Common Stock | Options Exercise | $162K | +1.38K | +8.55% | $117.85 | 17.5K | Nov 10, 2023 | Direct | |
transaction | RGA | Common Stock | Tax liability | -$98.9K | -610 | -3.49% | $162.15 | 16.9K | Nov 10, 2023 | Direct | F1 |
transaction | RGA | Common Stock | Options Exercise | $34.7K | +239 | +1.42% | $145.25 | 17.1K | Nov 10, 2023 | Direct | |
transaction | RGA | Common Stock | Tax liability | -$17.2K | -106 | -0.62% | $162.15 | 17K | Nov 10, 2023 | Direct | F2 |
transaction | RGA | Common Stock | Options Exercise | $17.5K | +116 | +0.68% | $150.87 | 17.1K | Nov 10, 2023 | Direct | |
transaction | RGA | Common Stock | Tax liability | -$8.43K | -52 | -0.3% | $162.15 | 17.1K | Nov 10, 2023 | Direct | F3 |
transaction | RGA | Common Stock | Options Exercise | $48.5K | +374 | +2.19% | $129.72 | 17.4K | Nov 10, 2023 | Direct | |
transaction | RGA | Common Stock | Tax liability | -$26.9K | -166 | -0.95% | $162.15 | 17.3K | Nov 10, 2023 | Direct | F4 |
transaction | RGA | Common Stock | Options Exercise | $44.8K | +421 | +2.44% | $106.53 | 17.7K | Nov 10, 2023 | Direct | |
transaction | RGA | Common Stock | Tax liability | -$30.3K | -187 | -1.06% | $162.15 | 17.5K | Nov 10, 2023 | Direct | F5 |
transaction | RGA | Common Stock | Options Exercise | $187K | +1.45K | +8.28% | $129.01 | 18.9K | Nov 10, 2023 | Direct | |
transaction | RGA | Common Stock | Tax liability | -$21.4K | -132 | -0.7% | $162.15 | 18.8K | Nov 10, 2023 | Direct | F6 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Stock Appreciation Right (right to purchase) 2020 | Options Exercise | $0 | -5.04K | -75% | $0.00 | 1.68K | Nov 10, 2023 | Common Stock | 5.04K | $117.85 | Direct | F7 |
transaction | RGA | Stock Appreciation Right (right to purchase) 2019 | Options Exercise | $0 | -2.29K | -100% | $0.00* | 0 | Nov 10, 2023 | Common Stock | 2.29K | $145.25 | Direct | F7 |
transaction | RGA | Stock Appreciation Right (right to purchase) 2018 | Options Exercise | $0 | -1.68K | -100% | $0.00* | 0 | Nov 10, 2023 | Common Stock | 1.68K | $150.87 | Direct | F7 |
transaction | RGA | Stock Appreciation Right (right to purchase) 2017 | Options Exercise | $0 | -1.87K | -100% | $0.00* | 0 | Nov 10, 2023 | Common Stock | 1.87K | $129.72 | Direct | F7 |
transaction | RGA | Stock Appreciation Right (right to purchase) 2022 | Options Exercise | $0 | -1.23K | -24.99% | $0.00 | 3.68K | Nov 10, 2023 | Common Stock | 1.23K | $106.53 | Direct | F7 |
transaction | RGA | Stock Appreciation Right (right to purchase) 2021 | Options Exercise | $0 | -1.45K | -49.98% | $0.00 | 1.45K | Nov 10, 2023 | Common Stock | 1.45K | $129.01 | Direct | F7 |
Id | Content |
---|---|
F1 | 1. Represents (i) 3,663 shares sold to pay the exercise price the purchase of common stock, and (ii) 610 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 766 shares. |
F2 | 1. Represents (i) 2,055 shares sold to pay the exercise price the purchase of common stock, and (ii) 106 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 133 shares. |
F3 | 1. Represents (i) 1,560 shares sold to pay the exercise price the purchase of common stock, and (ii) 52 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 64 shares. |
F4 | 1. Represents (i) 1,499 shares sold to pay the exercise price the purchase of common stock, and (ii) 166 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 208 shares. |
F5 | 1. Represents (i) 806 shares sold to pay the exercise price the purchase of common stock, and (ii) 187 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 234 shares. |
F6 | 1. Represents (i) 1,153 shares sold to pay the exercise price the purchase of common stock, and (ii) 132 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 164 shares. |
F7 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |